Researchers at VCU Massey Comprehensive Cancer Center have developed an experimental molecule called an autophagy-targeting chimera (AUTAC) that dismantles the MCL1 survival protein to kill multiple myeloma cells. According to a study published in Cell Death & Disease, this targeted protein degrader works with existing proteasome inhibitors to reduce cancer cell viability by 50% within … Read more
Research published in the journal Annals of Oncology indicates that GLP-1 receptor agonists (GLP-1 RAs) are associated with a 41% reduction in overall cancer risk among obese, non-diabetic adults. This study of more than 229,000 patients suggests these medications may offer significant benefits for cancer prevention beyond simple weight management. Which cancers are linked to … Read more
Breakthrough in Cancer Immunotherapy: How a Tiny Fraction of T Cells Could Revolutionize Multiple Myeloma Treatment By [Your Name], Cancer Immunotherapy Research Journalist Osaka, Japan — A groundbreaking study from researchers at Osaka University has uncovered a surprising truth about how the body fights cancer: in the battle against multiple myeloma, only a small group … Read more